VEA
SRRA

Virtus ETF Advisers’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Virtus ETF Advisers’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,888
Closed -$104K – 475
2022
Q2 		$104K Buy
+1,888
New +$99.1K 0.04% 425
2016
Q2 		– Sell
-448
Closed -$121K – 157
2016
Q1 		$121K Buy
+448
New +$143K 0.17% 136

Other funds holding SRRA

HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Virtus ETF Advisers's SRRA Position: Q3 2022 in Review

Virtus ETF Advisers sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 1,888 shares — an estimated $104K sold.

Virtus ETF Advisers first reported a position in SRRA in Q1 2016 and held it in 2 quarters. The position peaked at $121K in Q1 2016. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

  • Virtus ETF Advisers reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Virtus ETF Advisers sold 1,888 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $104K.
  • Virtus ETF Advisers first reported a position in Sierra Oncology, Inc. Common Stock in Q1 2016 and held it in 2 quarters.
  • Virtus ETF Advisers's Sierra Oncology, Inc. Common Stock position peaked at $121K in Q1 2016.
  • 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on Virtus ETF Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.